Medulloblastoma encompasses a collection of clinically and molecularly diverse tumour subtypes that together comprise the most common malignant childhood brain tumour [1] [2] [3] [4] . These tumours are thought to arise within the cerebellum, with approximately 25% originating from granule neuron precursor cells (GNPCs) after aberrant activation of the Sonic Hedgehog pathway (hereafter, SHH subtype) [3] [4] [5] [6] [7] [8] . The pathological processes that drive heterogeneity among the other medulloblastoma subtypes are not known, hindering the development of much needed new therapies. Here we provide evidence that a discrete subtype of medulloblastoma that contains activating mutations in the WNT pathway effector CTNNB1 (hereafter, WNT subtype) 1,3,4 arises outside the cerebellum from cells of the dorsal brainstem. We found that genes marking human WNTsubtype medulloblastomas are more frequently expressed in the lower rhombic lip (LRL) and embryonic dorsal brainstem than in the upper rhombic lip (URL) and developing cerebellum. Magnetic resonance imaging (MRI) and intra-operative reports showed that human WNT-subtype tumours infiltrate the dorsal brainstem, whereas SHH-subtype tumours are located within the cerebellar hemispheres. Activating mutations in Ctnnb1 had little impact on progenitor cell populations in the cerebellum, but caused the abnormal accumulation of cells on the embryonic dorsal brainstem which included aberrantly proliferating Zic1 1 precursor cells. These lesions persisted in all mutant adult mice; moreover, in 15% of cases in which Tp53 was concurrently deleted, they progressed to form medulloblastomas that recapitulated the anatomy and gene expression profiles of human WNT-subtype medulloblastoma. We provide the first evidence, to our knowledge, that subtypes of medulloblastoma have distinct cellular origins. Our data provide an explanation for the marked molecular and clinical differences between SHHand WNT-subtype medulloblastomas and have profound implications for future research and treatment of this important childhood cancer.
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SHH-subtype medulloblastoma is characterized by aberrant SHH signalling that is often driven by inactivating mutations in PTCH1 3,4 . These medulloblastomas tend to arise in very young children, display a 'large cell-anaplastic' or 'desmoplastic' histology and have a relatively poor prognosis [2] [3] [4] . WNT-subtype medulloblastomas are strikingly different. Arising in much older children, these highly curable tumours have 'classic' morphology and activating mutations in CTNNB1 1-4 . Mouse models have shown that SHH-subtype medulloblastomas arise from committed GNPCs of the cerebellum 7, 8 and enabled the development of new therapies that suppress the oncogenic SHH-signal 9, 10 . It has been suggested that the other medulloblastoma subtypes might have a different cellular origin 5, 11, 12 , but little is known about their biology and there are no mouse models of these tumours.
Recently, we showed that subtypes of the brain tumour ependymoma arise from discrete populations of neural progenitor cells with which they share similar gene expression profiles 13 . Therefore, to determine if medulloblastoma subtypes also arise from discrete cell populations, we first used four online gene expression databases to chart the regional expression of 110 genes that mark human SHH-or WNT-subtype medulloblastomas 3 . Twenty-four WNT-subtype and 25 SHH-subtype medulloblastoma signature genes are contained within 'Brain Explorer 2', which generates three-dimensional gene expression maps across the mouse brain (www.brain-map.org, Supplementary Methods and Supplementary Data set 1). As expected 14 , these data revealed the URL at embryonic day (E) 11.5 and the cerebellum at E15.5 to be the most common sites of SHH-subtype signature gene expression ( Fig. 1a , b and Supplementary Data Set 1). In contrast, WNT-subtype medulloblastoma signature genes were predominantly expressed within the LRL at E11.5 (rhombomeres (r) 2-r8) and the dorsal brainstem at E15.5. Expression of an additional 61 medulloblastoma signature genes, reported by three other online databases, confirmed this differential pattern (Supplementary Fig. 1 and Supplementary Table 1 ). These data suggest that SHH-and WNT-subtype medulloblastomas arise from distinct regions of the hindbrain and identify the dorsal brainstem as a potential source of WNT-subtype tumours.
If SHH-and WNT-subtype medulloblastomas have different origins, we reasoned that these tumours should demonstrate anatomical differences at diagnosis. Remarkably, all validated WNT-subtype medulloblastomas examined (n 5 6/6, Supplementary Fig. 2 ) were located within the IV ventricle and infiltrated the dorsal surface of the brainstem, whereas all SHH-subtype tumours (n 5 6/6) were distributed away from the brainstem within the cerebellar hemispheres ( Fig. 1c, d and Supplementary Fig. 3 , exact Mann-Whitney P , 0.005). Five of the six WNT-subtype, but no SHH-subtype, tumours were adherent to the dorsal brainstem at surgery (Fisher's exact test, P , 0.005). Thus WNTsubtype medulloblastomas are anatomically distinct from SHH tumours and are intimately related to the IV ventricle and dorsal brainstem.
We noted various cell types surrounding the IV ventricle that could give rise to WNT-subtype medulloblastomas, including dorsal brainstem progenitors of cochlear, mossy-fibre and climbing-fibre neurons (Fig. 1a, b and Supplementary Fig. 4 ) 15 . But it remained possible that cerebellar ventricular-zone radial glia 12, 16 or GNPCs generate WNT-subtype medulloblastomas. To identify hindbrain cells that are susceptible to transformation by Ctnnb1, we generated mice carrying a cre-dependent mutant allele of Ctnnb1 (Ctnnb1 lox(ex3) ) 17 and the Blbp-Cre transgene 18 . Blbp-Cre induces efficient recombination in progenitor cell populations across the hindbrain including the cerebellar ventricular zone, GNPCs of the external germinal layer (EGL) and Olig3 1 progenitor cells in the LRL 19 ( Supplementary Fig. 5 ). We also generated Blbp-Cre 1/2 ;Ctnnb1 1/lox(ex3) (hereafter, Ctnnb1-mutant) mice that were homozygous for a cre-dependent mutant allele of Tp53 (Tp53 flx ) 20 because loss of this tumour suppressor accelerates medulloblastoma formation in Ptch1 1/2 mice 21 . As expected, Ctnnb1-mutant embryos expressed mutant nuclear-Ctnnb1 in all hindbrain germinal zones, regardless of Tp53 status ( Supplementary Figs 5k and 6) . Surprisingly, mutation of Ctnnb1 did not affect significantly the proliferation or apoptosis of ventricular-zone cells or GNPCs in the cerebellum ( Fig. 2a and Supplementary Fig. 7 ).
Because GNPCs generate SHH-subtype medulloblastomas 7,8 , we sought additional evidence that these cells are not impacted by mutant Ctnnb1. First, we generated Atoh1-Cre 1/2 ;Ctnnb1 1/lox(ex3) mice because Atoh1-Cre drives efficient recombination in GNPCs, generating medulloblastomas in conditional Ptch1 mice (see Supplementary  Fig. 8a -j and ref. 7) . We also used the Atoh1 enhancer element present in the Atoh1-Cre allele to drive expression of a constitutively active Ctnnb1-green fluorescence fusion protein (GFP) in GNPCs (Atoh1-Ctnnb1 DN90GFP , Supplementary Fig. 8k -o) 22 . Neither Atoh1-Cre 1/2 ; Ctnnb1 1/lox(ex3) nor Atoh1-Ctnnb1 DN90GFP mice (more than 20 mice examined each) developed hyperplasia or masses within the URL or EGL. Concordantly, aberrant Ctnnb1 signalling did not impact the proliferation of GNPCs ex vivo ( Supplementary Fig. 8p ). Thus, in contrast to aberrant Shh signalling, mutant Ctnnb1 does not appear to disrupt cell-cycle or differentiation control in GNPCs.
In stark contrast to the cerebellum, by E16.5 all Ctnnb1-mutant mice developed aberrant cell collections in the dorsal brainstem that persisted into adulthood (exact Mann-Whitney P , 0.005, Fig. 2a-f ). These cells were marked by Olig3 and Pax6, which suggested they may be derived from progenitor cells within the LRL 19, 23 (Fig. 2d, e ). This abnormality was independent of Tp53 status and did not involve the floor plate that is not targeted by Blbp-Cre ( Supplementary Fig. 9 ). Progenitors within the embryonic dorsal brainstem proliferate to produce daughter cells that express specific marker proteins and follow complex migration streams to their respective nuclei in the developing brainstem ( Supplementary Fig. 4 ) 15 . We observed no significant differences in the overall proliferation (Ki67 labelling), apoptosis (TdT-mediated dUTP nick end labelling) or cell-cycle duration (5bromo-2-deoxyuridine pulse-chase) of progenitors in the dorsal brainstem of Ctnnb1-mutant versus control mice ( Fig. 2c , data not shown). However, a significant fraction of proliferating cells within Ctnnb1mutant dorsal brainstems expressed Zic1 (37% Zic1 1 /Ki67 1 5 122/ 322; Fig. 2c , f-h). This expression is aberrant because Zic1 normally marks postmitotic mossy-fibre neuron precursors as they exit the dorsal brainstem to form nuclei in the ventral brainstem 23, 24 (Fig. 2g ). Thus mutant Ctnnb1 might stall the dorso-ventral migration of brainstem neuron precursors, resulting in aberrant dorsal cell collections 25 . To test this, we used in utero GFP electroporation to track the fate of embryonic dorsal brainstem precursors ( Supplementary Fig. 11 ). In contrast, mutation of Ctnnb1 markedly reduced the numbers of precursors transiting from the dorsal brainstem to the pontine grey nucleus ( Fig. 2o-q ; exact Mann-Whitney, P , 0.05). Together, these data demonstrate that mutant Ctnnb1 disrupts the normal differentiation and migration of progenitor cells on the dorsal brainstem, resulting in the accumulation of aberrant cell collections. These cells may include stalled mossy-fibre neuron precursors, but further work is required to determine their precise lineage.
Aberrant cell collections in the dorsal brainstem of Ctnnb1-mutant mice are reminiscent of the EGL hyperplasia that precedes formation of SHH-subtype medulloblastoma in the cerebellum of Ptch1-deficient mice 26 . Therefore we aged Ctnnb1-mutant mice harbouring Tp53 1/1 , Tp53 1/flx or Tp53 flx/flx alleles to test if WNT-subtype medulloblastomas might arise from the dorsal brainstem (n more than 54 mice per genotype). Aberrant cell collections persisted throughout adulthood on the dorsal brainstem of all Ctnnb1-mutant;Tp53 1/1 mice, but these animals did not develop medulloblastoma or tumours in any part of the hindbrain (median follow up 365 days). In contrast, 2 out of 10 Ctnnb1-mutant;Tp53 flx/flx mice aged older than 6 months harboured asymptomatic tumours that were confined to the dorsal brainstem (Supplementary Fig. 12 ). When aged for longer periods, 15% (n 5 8/55) of Ctnnb1-mutant;Tp53 flx/flx and 4% (n 5 2/54) Ctnnb1-mutant;Tp53 1/flx 
RESEARCH LETTER
mice developed 'classic' medulloblastomas that were Zic1 1 and contained populations of nuclear-Ctnnb1 1 /Olig3 1 cells (median follow up 290 and 287 days, respectively; Fig. 3a-d) . These mouse medulloblastomas displayed an immunoprofile similar to human WNT-subtype tumours and were invariably connected with the brainstem (Fig. 3d, e and Supplementary Fig. 13 ). In contrast, mouse models of human SHHsubtype medulloblastoma 21, 27, 28 are nuclear-Ctnnb1 negative, arise within the cerebellum and do not invade the brainstem (Fig. 3d, e ). Together, these data support the hypothesis that progenitor cells within the dorsal brainstem are susceptible to transformation by concurrent mutation in Ctnnb1 and Tp53, resulting in the formation of tumours that mimic the anatomical features of human WNT-subtype medulloblastoma. Deletion of Tp53 is presumably required to allow key second mutations during transformation of the LRL in Ctnnb1-mutant mice. Notably, we have observed two cases of TP53-mutant human WNTsubtype medulloblastoma, suggesting this gene also suppresses these tumours in humans ( Supplementary Fig. 14) .
To test further the fidelity of Ctnnb1-mutant mouse medulloblastoma as a model of human WNT-subtype disease, we compared the tumour transcriptomes in the two species using an algorithm we have 
developed for cross-species genomic comparisons 13 . Remarkably, the transcriptome (n 5 11,049 orthologues) of Ctnnb1-mutant;Tp53 flx/flx medulloblastomas matched only human WNT-subtype medulloblastoma and the cells of the embryonic dorsal brainstem (both permuted P , 0.05), validating it as a model of this human tumour subtype and further pinpointing the brainstem as the source of WNT-subtype medulloblastomas (Fig. 4a, b ). Finally, because human WNT-subtype medulloblastomas selectively delete chromosome 6 (ref.
3), we looked in Ctnnb1-mutant mouse medulloblastomas to see if syntenic regions of this chromosome are deleted (Fig. 4c ). DNA microarray analysis identified a single common deletion of mouse chromosome 17 3.2 cM/ human 6q25.3 in tumours in the two species. This locus encodes a single gene, TULP4, that is a distant member of the tubby-gene family implicated in regulating neuronal cell apoptosis 29 . Thus Ctnnb1mutant;Tp53 flx/flx mouse medulloblastomas accurately model the molecular characteristics of human WNT-subtype tumours and pinpoint TULP4 as a novel candidate suppressor gene of these tumours. By demonstrating that subtypes of medulloblastoma have distinct cellular origins, our data should significantly accelerate the hunt for curative treatments of these diseases, which must now account for the different developmental origins of these tumours.
METHODS SUMMARY
MRI analysis. MRI images of patients were spatially normalized into a standard stereotaxic space for quantitative comparison of tumour location (SPM5; www.fil. ion.ucl.ac.uk/spm). Radiologists masked to patient subtype determined the threedimensional location of the tumour or surgical cavity relative to pre-defined anatomical landmarks. Expression mapping. The expression of mouse orthologues of key signature genes of human WNT-and SHH-subtype medulloblastoma (Supplementary Data Set 1 and Supplementary Table) were mapped in the developing mouse hindbrain using four publically accessible data sets (see Supplementary Methods) .
Mouse studies. Blbp-Cre, Ctnnb1 lox(ex3)/lox(ex3) , Atoh1-Cre and Tp53 flx/flx mice were bred to generate appropriate genotypes and subjected to clinical surveillance for signs of tumour development. RosaYFP and RosaLacz reporter strains traced the lineage of Cre-recombined cells. Mouse tumours comprised at least 85% tumour cells. Atoh1-Ctnnb1 DN90 transgenic mice were generated by pro-nuclear injection. In utero electroporation and cell tracking were performed by anaesthetizing pregnant mice of the appropriate genotype. The uterus was externalized and the dorsal brainstem of E12.5 embryos electroporated with CMV-eGFP plasmid DNA. GNPCs for culture studies were isolated from postnatal day 7 Atoh1-GFP transgenic mice. GFP 1 cells (2 3 10 5 per well) were cultured in poly-D-lysinecoated 96-well plates and challenged with mutant-Ctnnb1-GFP, control GFP virus, Wnt1 protein (50 ng ml 21 ) or Shh supernatant (3 mg ml 21 ) before pulsing with [methyl-3H]thymidine and scintillation counting. Histology, messenger RNA and DNA microarray profiling. Immunohistochemistry was performed using routine techniques and primary antibodies of the appropriate tissues as described ( Supplementary Methods) . Cells undergoing apoptosis were detected with the Apoptag kit (Millipore, S7100). Messenger RNA expression (GEO accession number GSE24628) and DNA copy number profiles (available at http://stjuderesearch.org/site/authors/gilbertson) were generated from mouse and human tissues using appropriate microarray platforms as detailed (Supplementary Methods). Reverse transcriptase real-time PCR and gene resequencing of human medulloblastomas were performed as described previously 3 . Messenger RNA expression and DNA microarray profiles of human and mouse medulloblastomas were integrated using established and novel bioinformatic and statistical approaches.
